3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
5
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Pain
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Flushing
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Driving Under the Influence
1
Depression
1
Colorectal Neoplasms
1
Carney Complex
1
Cardiovascular Diseases
1
Binge-Eating Disorder
1
Binge Drinking
1
Alzheimer Disease
1
Agnosia
1
Interventions
pirtobrutinib
6
Cyclophosphamide
6
Mycophenolic Acid
5
fludarabine phosphate
4
fludarabine
4
Rituximab
4
Melphalan
4
Azacitidine
4
venetoclax
3
ibrutinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Mesna
3
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Lenalidomide
2
Cyclosporine
2
Busulfan
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
zanubrutinib
1
ruxolitinib
1
ponatinib
1
pembrolizumab
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
cedazuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Ethanol
×
1 year
×
Clear all
No trials found.